BACKGROUND. It is common protocol in radionuclide therapies to adminis
ter a tracer dose of a radiopharmaceutical, determine its lesion uptak
e and biodistribution by gamma imaging, and then use this information
to determine the most effective therapeutic dose. This treatment plann
ing approach can be used to quantitate accurately the activity and vol
ume of lesions and organs with positron emission tomography (PET). In
this article, the authors focus on the specification of appropriate vo
lumes of interest (Vol) using PET in association with computed tomogra
phy (CT). METHODS. The authors have developed an automatic image segme
ntation schema to determine the Vol of metastases to the lung from PET
images, under conditions of variable background activity. An elliptic
al Jaszczak phantom containing a set of spheres with volumes ranging f
rom 0.4 to 5.5 mL was filled with F-18 activity (2-3 mu Ci/mL) corresp
onding to activities clinically observed in lung lesions. Images were
acquired with a cold background and then with variable source-to-backg
round (S/B) ratios of: 7.4, 5.5, 3.1, and 2.8. Lesion Vol analysis was
performed on 10 patients with 17 primary or metastatic lung lesions,
applying the optimum threshold values derived from the phantom experim
ents. Initial volume estimates for lung lesions were determined from C
T images. Approximate S/B ratios were obtained for the corresponding l
esions on F-18-fluoro-2-deoxy-D-glucose ((18)FDG)-PET images. From the
CT estimate of the lesion size and the PET estimate of the S/B ratio,
the appropriate optimum threshold could be chosen. The threshold was
applied to the PET images to obtain lesion activity and a final estima
te of the lesion volume. RESULTS. Phantom data analysis showed that im
age segmentation converged to a fixed threshold value (from 36% to 44%
) for sphere volumes larger than 4 mL, with the exact value depending
on the S/B ratios. For patients, the use of optimum threshold schema d
emonstrated a good correlation (r = 0.999) between the initial volume
from CT and the final volume derived from the (18)FDG-PET scan (P < 0.
02). The mean difference for those volumes was 8.4%. CONCLUSIONS. The
adaptive thresholding method applied to PET scans enables the definiti
on of tumor Vol, which hopefully leads to accurate tumor dosimetry. Th
is method can also be applied to small lesions (<4 mL). It should enab
le physicians to track objectively changes in disease status that coul
d otherwise be obscured by the uncertainties in the region-of-interest
drawing, even when the scans are delineated by the same physician. (C
) 1997 American Cancer Society.